A study to test the effectiveness of the I-DECIDED device assessment tool in improving care and prompt removal of invasive devices in adult hospital patients.

Not Applicable

Withdrawn

• Conditions: Invasive medical devices; Infection - Studies of infection and infectious agents; Cardiovascular - Other cardiovascular diseases; Renal and Urogenital - Other renal and urogenital disorders; Public Health - Health service research

• Registration Number: ACTRN12620000373976
• Lead Sponsor: Dr Gillian Ray-Barruel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-17
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

•Patients over 18 years with an invasive device and able to provide informed verbal consent to participate in device audits.
•Nurses and medical staff working clinically on the medical and surgical wards where the project will take place, and who provide informed written consent to participate in focus groups.

Exclusion Criteria

•Patients with any communication or linguistic difficulties.
•Patients admitted for palliative treatment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of idle devices: Idle device is defined as a temporary invasive device with no medical indication for the past 24–48 hours or anticipated use in next 24–48 hours, as indicated in the patient chart.[Weekly data collection during T1 and T3.];Prevalence of device complications, as reported in patient chart or RiskMan database. <br>Known potential complications or adverse events related to all invasive devices include patient discomfort, dislodgement, occlusion, pressure injury, or medical adhesive related skin injury (MARSI). Vascular access devices may also result in infiltration, extravasation, bleeding and nerve damage. [Weekly data collection during T1 and T3.]

Secondary Outcome Measures

Name	Time	Method
Prevalence of confirmed device-related infection, as per the hospital Infection Management reports, including prevalence of CLABSI, CAUTI, and S. aureus bacteraemia BSI.[Weekly data collection during T1 and T3.];Central line device utilisation ratios will be calculated as catheter-days divided by patient days.[Weekly data collection during T1 and T3.];Indwelling urinary catheters device utilisation ratios will be calculated as catheter-days divided by patient days.[Weekly data collection during T1 and T3.];PIVC device utilisation ratios will be calculated as number of PIVCs per total number of patients per ward, and number of PIVCs per patient[Weekly data collection during T1 and T3.];Staff focus group feedback on usability of I-DECIDED® tool and the barriers and enablers to device assessment and decision making[During the final month of T3.];Proportion of days where a device plan was documented in the iEMR.[Weekly data collection during T1 and T3.]